Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2017, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2017-10-25
DOI
10.1155/2017/6716419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer
- (2015) Xiaoqin Wu et al. TUMOR BIOLOGY
- Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment
- (2014) Marcos Vinícius Clarindo et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome
- (2014) S. R. Vartoukian et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mechanisms of Jak/STAT Signaling in Immunity and Disease
- (2014) Alejandro V. Villarino et al. JOURNAL OF IMMUNOLOGY
- Mediators of Mast Cells in Bullous Pemphigoid and Dermatitis Herpetiformis
- (2014) Agnieszka Zebrowska et al. MEDIATORS OF INFLAMMATION
- JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
- (2014) Leeyen Hsu et al. Journal of Immunology Research
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
- (2013) H. L. M. Rajala et al. BLOOD
- Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies
- (2013) Ada Lo Schiavo et al. CLINICS IN DERMATOLOGY
- Janus Kinases: An Ideal Target for the Treatment of Autoimmune Diseases
- (2013) Massimo Gadina JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS
- STAT1 expression and activation is increased in lesional psoriatic skin
- (2012) A. Hald et al. BRITISH JOURNAL OF DERMATOLOGY
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Pemphigoid diseases: Pathogenesis, diagnosis, and treatment
- (2011) Michael Kasperkiewicz et al. AUTOIMMUNITY
- Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population
- (2010) Lynnette R. Ferguson et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid
- (2009) Siavash Toosi et al. MEDICAL HYPOTHESES
- Selectivity and therapeutic inhibition of kinases: to be or not to be?
- (2009) Kamran Ghoreschi et al. NATURE IMMUNOLOGY
- Correlation of IgE Autoantibody to BP180 With a Severe Form of Bullous Pemphigoid
- (2008) Yohei Iwata et al. ARCHIVES OF DERMATOLOGY
- CCL18 is expressed in patients with bullous pemphigoid and parallels disease course
- (2008) C. Günther et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-5 and eosinophilia
- (2008) Kiyoshi Takatsu et al. CURRENT OPINION IN IMMUNOLOGY
- Investigation of Crohn's Disease Risk Loci in Ulcerative Colitis Further Defines Their Molecular Relationship
- (2008) Carl A. Anderson et al. GASTROENTEROLOGY
- Cytokine Signaling Modules in Inflammatory Responses
- (2008) John J. O'Shea et al. IMMUNITY
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started